Diatherix Laboratories is a CAP-accredited molecular diagnostic laboratory specializing in the precise detection of infectious diseases. In advance of the launch of a new diagnostic panel, the company sought to elevate brand awareness within the hospital and skilled nursing spaces and become thought leaders in the discussion of multi-drug resistant organisms (MDROs).
Strategy and Tactics
We partnered with Diatherix to help name, plan and promote ABX Crossroads, a scientific symposium to foster a national dialogue on the prevalence and detection of MDROs. The daylong conference engaged pharmacists, pharmacy directors, infection control officers and healthcare administrators in a multifaceted discussion about this growing healthcare crisis. Outreach and promotional activities included:
Results and Client Response
By all measures the premier ABX Crossroads event was an overwhelming success:
“Thank you so much for the invaluable support Lovell provided in helping us produce and present our symposium. We could not have done ABX Crossroads without you. From day one your creative approach, strategic thinking and professional connections were important factors in our success.”
– Betty Hawkins, Diatherix Vice President Strategic Initiatives
You posted your chargemaster. What now? Hospitals have largely complied with CMS’s rule to post charges, but more is needed to avoid being cast as the face of...
Nashville-based health care strategic communications firm Lovell Communications has added Philip Betbeze, former senior editor with HealthLeaders Media, as seni...